It has been reported that miR-185 targets IGF1 to activate the PI3K/AKT signaling pathway in an animal model of Parkinson’s disease [90] and induces autophagy via AKT signaling in hepatocellular carcinoma [91]. Here, AKT1 is linked to Parkinson disease.